ID   AOAH_HUMAN              Reviewed;         575 AA.
AC   P28039; A4D1Y5; B7Z490; Q53F13;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1992, sequence version 1.
DT   28-JUN-2023, entry version 183.
DE   RecName: Full=Acyloxyacyl hydrolase {ECO:0000303|PubMed:1883828};
DE            EC=3.1.1.77 {ECO:0000269|PubMed:1883828, ECO:0000269|PubMed:29343645, ECO:0000269|PubMed:8089145};
DE   Contains:
DE     RecName: Full=Acyloxyacyl hydrolase small subunit {ECO:0000303|PubMed:1883828};
DE   Contains:
DE     RecName: Full=Acyloxyacyl hydrolase large subunit {ECO:0000303|PubMed:1883828};
DE   Flags: Precursor;
GN   Name=AOAH {ECO:0000303|PubMed:1883828};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 35-49 AND
RP   157-185, FUNCTION, CATALYTIC ACTIVITY, SUBUNIT, PROTEOLYTIC CLEAVAGE, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=1883828; DOI=10.1021/bi00098a020;
RA   Hagen F.S., Grant F.J., Kuijper J.L., Slaughter C.A., Moomaw C.R., Orth K.,
RA   O'Hara P.J., Munford R.S.;
RT   "Expression and characterization of recombinant human acyloxyacyl
RT   hydrolase, a leukocyte enzyme that deacylates bacterial
RT   lipopolysaccharides.";
RL   Biochemistry 30:8415-8423(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Umbilical cord blood;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Synovial cell;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ASN-28.
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D.,
RA   Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z., Lu F., Zeesman S.,
RA   Nowaczyk M.J., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F., Belloni E.,
RA   Shaffer L.G., Pober B., Morton C.C., Gusella J.F., Bruns G.A.P., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M., Gripp K.W.,
RA   Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H., Teebi A.,
RA   Minassian B.A., Kere J., Armengol L., Pujana M.A., Estivill X.,
RA   Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P., Zlotorynski E.,
RA   Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ASN-28.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBUNIT, PROTEOLYTIC CLEAVAGE, SUBCELLULAR
RP   LOCATION, SIGNAL SEQUENCE CLEAVAGE SITE, GLYCOSYLATION AT ASN-59, AND
RP   MUTAGENESIS OF THR-61; SER-263; GLY-372 AND PRO-419.
RX   PubMed=8089145; DOI=10.1016/s0021-9258(17)31577-6;
RA   Staab J.F., Ginkel D.L., Rosenberg G.B., Munford R.S.;
RT   "A saposin-like domain influences the intracellular localization,
RT   stability, and catalytic activity of human acyloxyacyl hydrolase.";
RL   J. Biol. Chem. 269:23736-23742(1994).
RN   [9] {ECO:0007744|PDB:5W78, ECO:0007744|PDB:5W7C}
RP   X-RAY CRYSTALLOGRAPHY (2.23 ANGSTROMS) OF 24-152 AND 153-575 OF MUTANT
RP   ALA-263 IN COMPLEXES WITH CALCIUM; BACTERIAL LIPOPOLYSACCHARIDE CLEAVAGE
RP   PRODUCTS, FUNCTION, CATALYTIC ACTIVITY, ACTIVE SITE, MUTAGENESIS OF
RP   LYS-173; SER-263; ARG-345 AND LYS-379, SUBUNIT, GLYCOSYLATION AT ASN-59;
RP   ASN-207; ASN-409 AND ASN-466, DISULFIDE BONDS, PROTEOLYTIC CLEAVAGE, AND
RP   ACTIVITY REGULATION.
RX   PubMed=29343645; DOI=10.1073/pnas.1719834115;
RA   Gorelik A., Illes K., Nagar B.;
RT   "Crystal structure of the mammalian lipopolysaccharide detoxifier.";
RL   Proc. Natl. Acad. Sci. U.S.A. 115:E896-E905(2018).
CC   -!- FUNCTION: Removes the secondary (acyloxyacyl-linked) fatty acyl chains
CC       from the lipid A region of bacterial lipopolysaccharides
CC       (PubMed:1883828, PubMed:8089145, PubMed:29343645). By breaking down
CC       LPS, terminates the host response to bacterial infection and prevents
CC       prolonged and damaging inflammatory responses (By similarity). In
CC       peritoneal macrophages, seems to be important for recovery from a state
CC       of immune tolerance following infection by Gram-negative bacteria (By
CC       similarity). {ECO:0000250|UniProtKB:O35298, ECO:0000269|PubMed:1883828,
CC       ECO:0000269|PubMed:29343645, ECO:0000269|PubMed:8089145}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 3-(acyloxy)acyl derivative of bacterial toxin + H2O = 3-
CC         hydroxyacyl derivative of bacterial toxin + a fatty acid + H(+);
CC         Xref=Rhea:RHEA:12032, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:28868, ChEBI:CHEBI:136853, ChEBI:CHEBI:140675;
CC         EC=3.1.1.77; Evidence={ECO:0000269|PubMed:1883828,
CC         ECO:0000269|PubMed:29343645, ECO:0000269|PubMed:8089145};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|PubMed:29343645};
CC       Note=Binds 3 Ca(2+) ions per subunit. The calcium ions probably have a
CC       structural role. {ECO:0000269|PubMed:29343645};
CC   -!- ACTIVITY REGULATION: Inhibited by EDTA. {ECO:0000269|PubMed:29343645}.
CC   -!- SUBUNIT: Heterodimer of the large and small subunits; disulfide-linked.
CC       {ECO:0000269|PubMed:1883828, ECO:0000269|PubMed:29343645,
CC       ECO:0000269|PubMed:8089145}.
CC   -!- INTERACTION:
CC       P28039; Q15700: DLG2; NbExp=3; IntAct=EBI-1222067, EBI-80426;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:8089145,
CC       ECO:0000305|PubMed:1883828}. Cytoplasmic vesicle
CC       {ECO:0000269|PubMed:8089145}. Note=Detected in urine.
CC       {ECO:0000250|UniProtKB:O35298}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P28039-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P28039-2; Sequence=VSP_042571;
CC   -!- PTM: Cleaved into a large and a small subunit.
CC       {ECO:0000269|PubMed:1883828, ECO:0000269|PubMed:29343645,
CC       ECO:0000269|PubMed:8089145}.
CC   -!- PTM: The small subunit is N-glycosylated. {ECO:0000269|PubMed:8089145}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M62840; AAA35506.1; -; mRNA.
DR   EMBL; AK297016; BAH12476.1; -; mRNA.
DR   EMBL; AK223476; BAD97196.1; -; mRNA.
DR   EMBL; AC083876; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC087069; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH236951; EAL23977.1; -; Genomic_DNA.
DR   EMBL; CH471073; EAW94073.1; -; Genomic_DNA.
DR   EMBL; BC025698; AAH25698.1; -; mRNA.
DR   CCDS; CCDS5448.1; -. [P28039-1]
DR   CCDS; CCDS55102.1; -. [P28039-2]
DR   PIR; A40292; A40292.
DR   RefSeq; NP_001170977.1; NM_001177506.1.
DR   RefSeq; NP_001170978.1; NM_001177507.1. [P28039-2]
DR   RefSeq; NP_001628.1; NM_001637.3. [P28039-1]
DR   PDB; 5W78; X-ray; 2.27 A; A=24-152, B=153-575.
DR   PDB; 5W7C; X-ray; 2.23 A; A/B=24-152, C/D=153-575.
DR   PDBsum; 5W78; -.
DR   PDBsum; 5W7C; -.
DR   AlphaFoldDB; P28039; -.
DR   SMR; P28039; -.
DR   BioGRID; 106810; 1.
DR   IntAct; P28039; 2.
DR   STRING; 9606.ENSP00000479664; -.
DR   GuidetoPHARMACOLOGY; 2873; -.
DR   GlyCosmos; P28039; 4 sites, No reported glycans.
DR   GlyGen; P28039; 4 sites.
DR   iPTMnet; P28039; -.
DR   PhosphoSitePlus; P28039; -.
DR   BioMuta; AOAH; -.
DR   DMDM; 113976; -.
DR   EPD; P28039; -.
DR   MassIVE; P28039; -.
DR   PaxDb; P28039; -.
DR   PeptideAtlas; P28039; -.
DR   ProteomicsDB; 54435; -. [P28039-1]
DR   ProteomicsDB; 54436; -. [P28039-2]
DR   Antibodypedia; 26560; 159 antibodies from 24 providers.
DR   DNASU; 313; -.
DR   Ensembl; ENST00000612871.4; ENSP00000484305.1; ENSG00000136250.12. [P28039-2]
DR   Ensembl; ENST00000617537.5; ENSP00000483783.1; ENSG00000136250.12. [P28039-1]
DR   GeneID; 313; -.
DR   KEGG; hsa:313; -.
DR   MANE-Select; ENST00000617537.5; ENSP00000483783.1; NM_001637.4; NP_001628.1.
DR   UCSC; uc032zjw.2; human. [P28039-1]
DR   AGR; HGNC:548; -.
DR   CTD; 313; -.
DR   DisGeNET; 313; -.
DR   GeneCards; AOAH; -.
DR   HGNC; HGNC:548; AOAH.
DR   HPA; ENSG00000136250; Tissue enhanced (bone marrow, lymphoid tissue).
DR   MIM; 102593; gene.
DR   neXtProt; NX_P28039; -.
DR   OpenTargets; ENSG00000136250; -.
DR   PharmGKB; PA24838; -.
DR   VEuPathDB; HostDB:ENSG00000136250; -.
DR   eggNOG; ENOG502QVQW; Eukaryota.
DR   GeneTree; ENSGT00390000008427; -.
DR   HOGENOM; CLU_025769_0_0_1; -.
DR   InParanoid; P28039; -.
DR   OMA; PFCHLYP; -.
DR   OrthoDB; 4166at2759; -.
DR   PhylomeDB; P28039; -.
DR   TreeFam; TF329246; -.
DR   BRENDA; 3.1.1.77; 2681.
DR   PathwayCommons; P28039; -.
DR   SignaLink; P28039; -.
DR   BioGRID-ORCS; 313; 21 hits in 1155 CRISPR screens.
DR   ChiTaRS; AOAH; human.
DR   GeneWiki; AOAH; -.
DR   GenomeRNAi; 313; -.
DR   Pharos; P28039; Tchem.
DR   PRO; PR:P28039; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; P28039; protein.
DR   Bgee; ENSG00000136250; Expressed in granulocyte and 139 other tissues.
DR   ExpressionAtlas; P28039; baseline and differential.
DR   Genevisible; P28039; HS.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IEA:UniProtKB-KW.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0050528; F:acyloxyacyl hydrolase activity; IDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0006631; P:fatty acid metabolic process; IDA:UniProtKB.
DR   GO; GO:0009104; P:lipopolysaccharide catabolic process; IDA:UniProtKB.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; IBA:GO_Central.
DR   CDD; cd01826; acyloxyacyl_hydrolase_like; 1.
DR   Gene3D; 1.10.225.10; Saposin-like; 1.
DR   Gene3D; 3.40.50.1110; SGNH hydrolase; 1.
DR   InterPro; IPR039676; AOAH.
DR   InterPro; IPR001087; GDSL.
DR   InterPro; IPR008138; SapB_2.
DR   InterPro; IPR011001; Saposin-like.
DR   InterPro; IPR008139; SaposinB_dom.
DR   InterPro; IPR036514; SGNH_hydro_sf.
DR   PANTHER; PTHR15010; ACYLOXYACYL HYDROLASE; 1.
DR   PANTHER; PTHR15010:SF0; ACYLOXYACYL HYDROLASE; 1.
DR   Pfam; PF00657; Lipase_GDSL; 1.
DR   Pfam; PF03489; SapB_2; 1.
DR   SMART; SM00741; SapB; 1.
DR   SUPFAM; SSF47862; Saposin; 1.
DR   SUPFAM; SSF52266; SGNH hydrolase; 1.
DR   PROSITE; PS50015; SAP_B; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cytoplasmic vesicle;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Hydrolase;
KW   Lipid metabolism; Metal-binding; Reference proteome; Secreted; Signal;
KW   Zymogen.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000269|PubMed:8089145"
FT   PROPEP          24..34
FT                   /evidence="ECO:0000305|PubMed:1883828"
FT                   /id="PRO_0000020739"
FT   CHAIN           35..156
FT                   /note="Acyloxyacyl hydrolase small subunit"
FT                   /evidence="ECO:0000305|PubMed:1883828"
FT                   /id="PRO_0000020740"
FT   CHAIN           157..575
FT                   /note="Acyloxyacyl hydrolase large subunit"
FT                   /evidence="ECO:0000305|PubMed:1883828"
FT                   /id="PRO_0000020741"
FT   DOMAIN          37..118
FT                   /note="Saposin B-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00415"
FT   REGION          38..70
FT                   /note="Important for enzyme activity, localization to
FT                   cytoplasmic vesicles, and protein stability"
FT                   /evidence="ECO:0000269|PubMed:8089145"
FT   REGION          173..177
FT                   /note="Lipopolysaccharide binding"
FT                   /evidence="ECO:0000250|UniProtKB:O18823"
FT   ACT_SITE        263
FT                   /evidence="ECO:0000305|PubMed:29343645,
FT                   ECO:0000305|PubMed:8089145"
FT   BINDING         184
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:29343645"
FT   BINDING         186
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:29343645"
FT   BINDING         186
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:29343645"
FT   BINDING         188
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:29343645"
FT   BINDING         188
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:29343645"
FT   BINDING         190
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:29343645"
FT   BINDING         205
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:29343645"
FT   BINDING         205
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:29343645"
FT   BINDING         207
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:29343645"
FT   BINDING         208
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:29343645"
FT   BINDING         210
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:29343645"
FT   BINDING         213
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:29343645"
FT   BINDING         223
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000269|PubMed:29343645"
FT   BINDING         227
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000269|PubMed:29343645"
FT   BINDING         229
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000269|PubMed:29343645"
FT   BINDING         231
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000269|PubMed:29343645"
FT   BINDING         233
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000269|PubMed:29343645"
FT   BINDING         245
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000269|PubMed:29343645"
FT   SITE            345
FT                   /note="Interacts with lipopolysaccharide"
FT                   /evidence="ECO:0000250|UniProtKB:O18823"
FT   CARBOHYD        59
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:29343645,
FT                   ECO:0000305|PubMed:8089145, ECO:0007744|PDB:5W78"
FT   CARBOHYD        207
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:29343645,
FT                   ECO:0007744|PDB:5W78"
FT   CARBOHYD        409
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:29343645,
FT                   ECO:0007744|PDB:5W78"
FT   CARBOHYD        466
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:29343645,
FT                   ECO:0007744|PDB:5W78"
FT   DISULFID        41..114
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00415,
FT                   ECO:0000269|PubMed:29343645, ECO:0007744|PDB:5W78,
FT                   ECO:0007744|PDB:5W7C"
FT   DISULFID        44..108
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00415,
FT                   ECO:0000269|PubMed:29343645, ECO:0007744|PDB:5W78,
FT                   ECO:0007744|PDB:5W7C"
FT   DISULFID        70..83
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00415,
FT                   ECO:0000269|PubMed:29343645, ECO:0007744|PDB:5W78,
FT                   ECO:0007744|PDB:5W7C"
FT   DISULFID        123..453
FT                   /note="Interchain (between small and large subunit)"
FT                   /evidence="ECO:0000269|PubMed:29343645,
FT                   ECO:0007744|PDB:5W78, ECO:0007744|PDB:5W7C"
FT   DISULFID        160..169
FT                   /evidence="ECO:0000269|PubMed:29343645,
FT                   ECO:0007744|PDB:5W78, ECO:0007744|PDB:5W7C"
FT   DISULFID        206..230
FT                   /evidence="ECO:0000269|PubMed:29343645,
FT                   ECO:0007744|PDB:5W78, ECO:0007744|PDB:5W7C"
FT   DISULFID        249..329
FT                   /evidence="ECO:0000269|PubMed:29343645,
FT                   ECO:0007744|PDB:5W78, ECO:0007744|PDB:5W7C"
FT   DISULFID        376..459
FT                   /evidence="ECO:0000269|PubMed:29343645,
FT                   ECO:0007744|PDB:5W78, ECO:0007744|PDB:5W7C"
FT   VAR_SEQ         43..74
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_042571"
FT   VARIANT         28
FT                   /note="D -> N (in dbSNP:rs2228410)"
FT                   /evidence="ECO:0000269|PubMed:12690205, ECO:0000269|Ref.6"
FT                   /id="VAR_050663"
FT   VARIANT         166
FT                   /note="A -> T (in dbSNP:rs3735384)"
FT                   /id="VAR_020133"
FT   VARIANT         266
FT                   /note="A -> G (in dbSNP:rs3735386)"
FT                   /id="VAR_033513"
FT   MUTAGEN         61
FT                   /note="T->A: Loss of glycosylation. No effect on enzyme
FT                   activity or localization to cytoplasmic vesicles."
FT                   /evidence="ECO:0000269|PubMed:8089145"
FT   MUTAGEN         173
FT                   /note="K->E: No effect on enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:29343645"
FT   MUTAGEN         263
FT                   /note="S->A: Loss of enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:29343645"
FT   MUTAGEN         263
FT                   /note="S->L: Nearly abolishes catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:8089145"
FT   MUTAGEN         345
FT                   /note="R->E: No effect on enzyme activity; when associated
FT                   with E-379."
FT                   /evidence="ECO:0000269|PubMed:29343645"
FT   MUTAGEN         372
FT                   /note="G->M: Loss of enzyme activity with
FT                   lipopolysaccharide, due to steric hindrance. No effect on
FT                   activity with small, synthetic substrate."
FT                   /evidence="ECO:0000269|PubMed:29343645"
FT   MUTAGEN         379
FT                   /note="K->E: No effect on enzyme activity; when associated
FT                   with E-345."
FT                   /evidence="ECO:0000269|PubMed:29343645"
FT   MUTAGEN         419
FT                   /note="P->M: Loss of enzyme activity with
FT                   lipopolysaccharide, due to steric hindrance. No effect on
FT                   activity with small, synthetic substrate."
FT                   /evidence="ECO:0000269|PubMed:29343645"
FT   CONFLICT        222
FT                   /note="W -> C (in Ref. 6; BAD97196)"
FT                   /evidence="ECO:0000305"
FT   HELIX           38..57
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   HELIX           62..72
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   HELIX           76..78
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   HELIX           79..99
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   HELIX           104..110
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   STRAND          118..120
FT                   /evidence="ECO:0007829|PDB:5W78"
FT   HELIX           130..143
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   HELIX           159..161
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   HELIX           165..178
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   STRAND          192..198
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   TURN            199..201
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   HELIX           221..223
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   STRAND          224..226
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   STRAND          230..232
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   TURN            238..240
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   HELIX           244..249
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   STRAND          256..261
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   TURN            263..267
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   HELIX           272..274
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   HELIX           277..279
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   HELIX           282..285
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   HELIX           288..293
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   TURN            294..296
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   HELIX           299..301
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   TURN            303..305
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   STRAND          311..313
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   HELIX           319..326
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   HELIX           328..330
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   STRAND          334..338
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   TURN            344..346
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   HELIX           347..349
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   HELIX           351..353
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   TURN            358..360
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   STRAND          364..369
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   TURN            373..375
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   STRAND          379..381
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   TURN            383..385
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   HELIX           389..404
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   STRAND          411..416
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   HELIX           423..428
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   HELIX           434..436
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   TURN            437..440
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   HELIX           444..454
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   TURN            460..462
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   STRAND          463..465
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   HELIX           467..490
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   STRAND          496..501
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   HELIX           505..514
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   HELIX           519..522
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   TURN            525..527
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   STRAND          528..531
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   HELIX           533..550
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   HELIX           552..555
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   HELIX           562..569
FT                   /evidence="ECO:0007829|PDB:5W7C"
FT   TURN            570..573
FT                   /evidence="ECO:0007829|PDB:5W7C"
SQ   SEQUENCE   575 AA;  65105 MW;  E3B3853DBD308AF7 CRC64;
     MQSPWKILTV APLFLLLSLQ SSASPANDDQ SRPSLSNGHT CVGCVLVVSV IEQLAQVHNS
     TVQASMERLC SYLPEKLFLK TTCYLVIDKF GSDIIKLLSA DMNADVVCHT LEFCKQNTGQ
     PLCHLYPLPK ETWKFTLQKA RQIVKKSPIL KYSRSGSDIC SLPVLAKICQ KIKLAMEQSV
     PFKDVDSDKY SVFPTLRGYH WRGRDCNDSD ESVYPGRRPN NWDVHQDSNC NGIWGVDPKD
     GVPYEKKFCE GSQPRGIILL GDSAGAHFHI SPEWITASQM SLNSFINLPT ALTNELDWPQ
     LSGATGFLDS TVGIKEKSIY LRLWKRNHCN HRDYQNISRN GASSRNLKKF IESLSRNKVL
     DYPAIVIYAM IGNDVCSGKS DPVPAMTTPE KLYSNVMQTL KHLNSHLPNG SHVILYGLPD
     GTFLWDNLHN RYHPLGQLNK DMTYAQLYSF LNCLQVSPCH GWMSSNKTLR TLTSERAEQL
     SNTLKKIAAS EKFTNFNLFY MDFAFHEIIQ EWQKRGGQPW QLIEPVDGFH PNEVALLLLA
     DHFWKKVQLQ WPQILGKENP FNPQIKQVFG DQGGH
//
